Haemodynamic and catecholamine response to simulated ventricular tachycardia in man: Effect of baseline left ventricular function

Heart

Volumn 89, Issue 3, 2003, Pages 306-310

  Kolettis, T M ^a   Psarros, E ^b   Kyriakides, Z S ^b   Katsouras, C S ^a   Michalis, L K ^a   Sideris, D A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; CATECHOLAMINE RELEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE PACING; HEART VENTRICLE TACHYCARDIA; HEMODYNAMIC MONITORING; HUMAN; MALE; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROGNOSIS; RR INTERVAL; SIMULATION;

EID: 0037372440     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.3.306     Document Type: Article

References (25)

1. Josephson ME, Horowitz LN, Spielman SR, et al. Electrophysiologic and hemodynamic studies in patients resuscitated from cardiac arrest. Am J Cardiol 1980;46:948-55.
2. Steinbach KK, Merl O, Frohner K, et al. Hemodynamics during ventricular tachyarrhythmias. Am Heart J 1994;127:1102-6.
3. Hamer AWF, Rubin SA, Peter CT, et al. Factors that predict syncope during ventricular tachycardia in patients. Am Heart J 1984;107:997-1005.
4. Morady F, Halter JB, Di Carlo LA, et al. The interplay between endogenous catecholamines and induced ventricular tachycardia during electrophysiologic testing. Am Heart J 1987;113:227-34.
5. Cohen TJ, Liem B. Neuroendocrine responses of ventricular tachycardia in humans. Am Heart J 1991;121:1816-18.
6. Twidale N, Rayner TE, Menadue M, et al. Atrial natriuretic factor release during rapid ventricular pacing: Interplay between autonomic and hemodynamic stimulants. Am Heart J 1993;125:1638-44.
7. Peuhkurinen KJ, Uusimaa PA, Ruskoaho H, et al. Hemodynamic recovery, atrial natriuretic peptide and catecholamines during simulated ventricular tachycardia: effects of ventriculoatrial conduction. Pacing Clin Electrophysiol 1995;18:75-82.
8. Morady F, DiCarlo LA, Halter JD, et al. The plasma catecholamines response to ventricular tachycardia induction and external countershock during electrophysiologic testing. J Am Coll Cardiol 1986;8:584-91.
9. Maloney J, Khoury D, Simmons T, et al. Effect of atrioventricular synchrony on stroke volume during ventricular tachycardia in man. Am Heart J 1992;123:1561-8.
10. Smedes F, Kraak JC, Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr 1982;231:25-39.
11. Lima JAC, Weiss JL, Guzman PA, et al. Incomplete filling and incoordinate contraction as mechanisms of hypotension during ventricular tachycardia in man. Circulation 1983;68:928-38.
12. Saksena S, Ciccone JM, Craelius W, et al. Studies of left ventricular function during sustained ventricular tachycardia. J Am Coll Cardiol 1984;4:501-8.
13. Feldman T, Carroll JD, Munkenbeck F, et al. Hemodynamic recovery during simulated ventricular tachycardia: role of adrenergic receptor activation. Am Heart J 1988;115:576-87.
14. Burkhoff D, Sagawa K. Influence of pacing site on canine left ventricular force-interval relationship. Am J Physiol 1986;250:H414-18.
15. Kolettis TM, Kyriakides ZS, Popov T, et al. Importance of the site of ventricular tachycardia origin on left ventricular hemodynamics in man. Pacing Clin Electrophysiol 1999;22:871-9.
16. Ellenbogen KA, Smith ML, Thames MD, et al. Changes in regional adrenergic tone during sustained ventricular tachycardia associated with coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1990;65:1334-8.
17. Leimbach WN, Waltin BG, Victor RG, et al. Direct evidence From intrarenal recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986;73:913-19.
18. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-9.
19. Colucci WS, Ribeiro JP, Rocco MB, et al. Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization. Circulation 1989;80:314-29.
20. Hasking GJ, Esler MD, Jennings GL, et al. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986;73:615-21.
21. Liang CS, Fan TH, Sullebarger JT, et al. Decreased adrenergic neuronal uptake activity in experimental right heart failure. A chamber-specific contributor to beta-adrenoceptor downregulation. J Clin Invest 1989;84:1267-75.
22. Cappato R. Secondary prevention of sudden death: the Dutch study, the antiarrhythmics versus implantable defibrillator trial, the cardiac arrest study Hamburg, and the Canadian implantable defibrillator study. Am J Cardiol 1999;83:68-73D
23. Domanski MJ, Saksena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators (antiarrhythmics versus implantable defibrillators). J Am Coll Cardiol 1999;34:1090-5.
24. Sheldon R, Connolly S, Krahn A, et al. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian implantable defibrillator study. Circulation 2000;101:1660-4.
25. Klein H, Auricchio A, Reek S, et al. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Am J Cardiol 1999;83:91-7D.